55PEfficacy and safety of nintedanib and docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): First interim results of the ongoing non-interventional study VARGADO (NCT02392455)
Grohe, C, Gleiber, W, Haas, S, Mueller-Huesmann, H, Schulze, M, Atz, J, Kaiser, RVolume:
29
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy486.007
Date:
December, 2018
File:
PDF, 77 KB
2018